Oblique Therapeutics > News

News

28 Mar 2019

We welcome our new owners

07 Mar 2019

New collaboration with Pharma

10 Jan 2019

Oblique Therapeutics at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco

01 Nov 2018

09 Oct 2018

Oblique Therapeutics presents tumor growth inhibition and Treg-lowering data for OT-1096 in humanized mouse TNBC model at oncology congress ESMO

04 Sep 2018

Oblique Therapeutics opens office in Stockholm, Sweden

26 Apr 2018

15 Feb 2018

Research results on advanced cancer treatment published in renowned medical journal

«
1
2
3
4
»